The Ministry of Health is making changes to the regulatory legal acts governing the activities of pharmaceutical companies in Kazakhstan.
According to the press service of the department, the proposed measures are aimed at improving the investment climate, developing the industry and producing high-quality domestic pharmaceutical products with export potential.
New approaches provide for the expansion of preferences for pharmaceutical companies through the signing of Investment Agreements by decision of the Government of the Republic of Kazakhstan. At the same time, the term of the contracts will be determined based on the quality of the manufactured medicines and the level of localization of production.
The establishment of reciprocal obligations to develop export potential, among other things, should help contain prices for medicines within the country.
New investment projects will be accompanied by additional government support measures through the implementation of the Roadmap, which provides for the comprehensive strengthening of clinical and laboratory facilities.
Pharmaceutical products manufactured in accordance with good manufacturing practice standards will be available to the population within the framework of the guaranteed volume of free medical care.
Источник: Казахстанский Фармацевтический Вестник, pharmnews.kz
According to the press service of the department, the proposed measures are aimed at improving the investment climate, developing the industry and producing high-quality domestic pharmaceutical products with export potential.
New approaches provide for the expansion of preferences for pharmaceutical companies through the signing of Investment Agreements by decision of the Government of the Republic of Kazakhstan. At the same time, the term of the contracts will be determined based on the quality of the manufactured medicines and the level of localization of production.
The establishment of reciprocal obligations to develop export potential, among other things, should help contain prices for medicines within the country.
New investment projects will be accompanied by additional government support measures through the implementation of the Roadmap, which provides for the comprehensive strengthening of clinical and laboratory facilities.
Pharmaceutical products manufactured in accordance with good manufacturing practice standards will be available to the population within the framework of the guaranteed volume of free medical care.
Источник: Казахстанский Фармацевтический Вестник, pharmnews.kz
